BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27632344)

  • 1. Novel
    Liu M; Zheng Y; Avcibasi U; Liu S
    Nucl Med Biol; 2016 Nov; 43(11):732-741. PubMed ID: 27632344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of boronate capping groups on biological characteristics of novel (99m)Tc(III) complexes [(99m)TcCl(CDO)(CDOH)2B-R] (CDOH2 = cyclohexanedione dioxime).
    Yang Y; Zheng Y; Tomaselli E; Fang W; Liu S
    Bioconjug Chem; 2015 Feb; 26(2):316-28. PubMed ID: 25585053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel
    Liu M; Fang W; Liu S
    Bioconjug Chem; 2016 Nov; 27(11):2770-2779. PubMed ID: 27737549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of co-ligands on chemical and biological properties of (99m)Tc(III) complexes [(99m)Tc(L)(CDO)(CDOH)2BMe] (L=Cl, F, SCN and N3; CDOH2=cyclohexanedione dioxime).
    Zheng Y; Ji S; Tomaselli E; Ernest C; Freiji T; Liu S
    Nucl Med Biol; 2014; 41(10):813-24. PubMed ID: 25169135
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Liu M; Liu S
    Dalton Trans; 2017 Oct; 46(42):14509-14518. PubMed ID: 29087405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfonyl-Containing Boronate Caps for Optimization of Biological Properties of
    Zhao ZQ; Liu M; Fang W; Liu S
    J Med Chem; 2018 Jan; 61(1):319-328. PubMed ID: 29186661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Approach for
    Liu M; Zhao ZQ; Fang W; Liu S
    Bioconjug Chem; 2017 Dec; 28(12):2998-3006. PubMed ID: 29148726
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Xi XY; Wang L; Hsu B; Zhao ZQ; Liu S; Fang W
    J Nucl Cardiol; 2021 Dec; 28(6):2687-2696. PubMed ID: 32180138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neutral technetium-99m complex for myocardial imaging.
    Narra RK; Nunn AD; Kuczynski BL; Feld T; Wedeking P; Eckelman WC
    J Nucl Med; 1989 Nov; 30(11):1830-7. PubMed ID: 2809747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kit formulated asialoglycoprotein receptor targeting tracer based on copolymer for liver SPECT imaging.
    Liu C; Guo Z; Zhang P; Song M; Zhao Z; Wu X; Zhang X
    Nucl Med Biol; 2014 Aug; 41(7):587-93. PubMed ID: 24815356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties.
    Boschi A; Uccelli L; Bolzati C; Duatti A; Sabba N; Moretti E; Di Domenico G; Zavattini G; Refosco F; Giganti M
    J Nucl Med; 2003 May; 44(5):806-14. PubMed ID: 12732683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of novel cationic (99m)Tc-nitrido complexes as radiopharmaceuticals for heart imaging: improving liver clearance with crown ether groups.
    Liu S; He Z; Hsieh WY; Kim YS
    Nucl Med Biol; 2006 Apr; 33(3):419-32. PubMed ID: 16631092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New
    Fang W; Liu S
    Curr Radiopharm; 2019; 12(3):171-186. PubMed ID: 30727939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion.
    Beanlands RS; DeKemp RA; Harmsen E; Veinot JP; Hartman NG; Ruddy TD
    J Am Coll Cardiol; 1996 Aug; 28(2):487-94. PubMed ID: 8800130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial evaluation of
    Liu J; Wang H; Wang S; Xue Q; Wang D; Wang H; Zhang H
    J Labelled Comp Radiopharm; 2017 May; 60(5):250-262. PubMed ID: 28185309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid hepatic clearance of 99mTc-TMEOP: a new candidate for myocardial perfusion imaging.
    Goethals LR; Santos I; Caveliers V; Paulo A; De Geeter F; Lurdes PG; Fernandes C; Lahoutte T
    Contrast Media Mol Imaging; 2011; 6(4):178-88. PubMed ID: 21861278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kit formulation for preparation and biological evaluation of a novel (99m)Tc-oxo complex with metronidazole xanthate for imaging tumor hypoxia.
    Li Z; Lin X; Zhang J; Wang X; Jin Z; Zhang W; Zhang Y
    Nucl Med Biol; 2016 Feb; 43(2):165-70. PubMed ID: 26872441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of neutral and cationic myocardial perfusion agents: characteristics of accumulation in cultured cells.
    Kronauge JF; Chiu ML; Cone JS; Davison A; Holman BL; Jones AG; Piwnica-Worms D
    Int J Rad Appl Instrum B; 1992 Feb; 19(2):141-8. PubMed ID: 1601667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological in vitro and in vivo studies of a series of new asymmetrical cationic [99mTc(N)(DTC-Ln)(PNP)]+ complex (DTC-Ln = alicyclic dithiocarbamate and PNP = diphosphinoamine).
    Bolzati C; Cavazza-Ceccato M; Agostini S; Refosco F; Yamamichi Y; Tokunaga S; Carta D; Salvarese N; Bernardini D; Bandoli G
    Bioconjug Chem; 2010 May; 21(5):928-39. PubMed ID: 20402465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.